Exploring the Potential Role of CYP2C19 Genetic Variability in Cenobamate Treatment
<b>Background:</b> Cenobamate is a novel antiseizure medication with potential interactions involving cytochrome P450 enzymes, including CYP2C19. Genetic variability in CYP2C19 may influence drug metabolism and tolerability, although its clinical relevance in cenobamate-treated patients remains uncl...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2026-06-01
|
| Serie: | Applied Sciences |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2076-3417/16/11/5679 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|